Literature DB >> 1756560

Do stents interfere with the densitometric assessment of a coronary artery lesion?

B H Strauss1, B J Rensing, A den Boer, W J van der Giessen, J H Reiber, P W Serruys.   

Abstract

This in vitro study was designed to assess the contribution of three currently investigated coronary stents to the densitometric measurement of a known stenosis contained within two different sized plexiglass phantoms. These studies were performed at two concentrations of the contrast agent iopamidol (50 and 100%). The calculated minimal luminal cross-sectional area values in the control phantom ranged from 0-18% higher than the theoretical values. Insertion of a stainless steel stent (Wallstent, Schneider, Zürich or Palmaz-Schatz, Johnson and Johnson, Warren, NJ) resulted in further minor increases (less than or equal to 8% in the calculated minimal luminal cross-sectional area, except in the smaller phantom filled with 50% contrast medium. The Wiktor (tantalum) stent (Medtronic, Minneapolis, MN) had the largest impact of the three stents depending on the concentration of iopamidol (100% contrast medium: 9-13% values above control; 50% contrast medium; 23-56% higher). We conclude that although densitometry may overestimate the minimal luminal cross-sectional area in stented vessels, this effect is usually minor with stainless steel stents. However, tantalum-containing stents may result in serious overestimation of lesion area, particularly if contrast is diluted or the vessel is not well filled.

Entities:  

Mesh:

Year:  1991        PMID: 1756560     DOI: 10.1002/ccd.1810240408

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  1 in total

1.  Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT.

Authors:  Juan Luis Gutiérrez-Chico; Patrick W Serruys; Chrysafios Girasis; Scot Garg; Yoshinobu Onuma; Salvatore Brugaletta; Héctor García-García; Gerrit-Anne van Es; Evelyn Regar
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-26       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.